Release Date: 31/08/16 16:18 Summary: Appendix 4E Preliminary Final Report-ILH.AX Price Sensitive: No Download Document 396.33KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%